Abbott Laboratories (ABT) traded up 1.14 % during a 24 hours period ending at 09:58 AM Central Europe on Tuesday 27th. One Abbott Laboratories stock can currently be bought for about USD 104.88 on popular exchanges. Current supply of Abbott Laboratories stocks is 1.7 bn. Abbott Laboratories has a current market capitalization of USD 180.2 bn and approximately USD 822.3 mn worth of Abbott Laboratories was traded on exchanges in the last 24 hours. Since last month end, Abbott Laboratories has traded 3.86 % up. Simple moving average of last 200 days is at USD 102.11. The highest price of past 52 weeks was recorded at USD 132.03 on 11/18/2025. 52 weeks low was at USD 81.97 on 05/11/2026.

Here is how related stocks have performed in the past 24 hours:

  • Analog Devices (ADI) traded up 4.31 % and now trades at USD 407.93. Analog Devices has a market capitalisation of USD 192.6 bn. Current price/earnings ratio for Analog Devices is 46.46.

  • Gilead Sciences (GILD) traded up 1.7 % and now trades at USD 158.69. Gilead Sciences has a market capitalisation of USD 196.3 bn. Gilead Sciences has announced a collaboration with Innovaccer to extend the reach of its oncology data platform. The partnership aims to integrate Gilead’s real‑world evidence into Innovaccer’s AI‑driven analytics, enhancing insights for cancer treatment development. No financial terms were disclosed. The move follows Gilead’s recent focus on data‑driven oncology solutions, complementing its existing drug portfolio and supporting its broader strategy to leverage digital tools for patient outcomes. No immediate impact on share price has been reported.

  • Walt Disney /The (DIS) traded flat 0 % and now trades at USD 110.4. Walt Disney /The has a market capitalisation of USD 193.9 bn. Current price/earnings ratio for Walt Disney /The is 23.26. Walt Disney shares traded on the NYSE today experienced a slight decline, reflecting modest pressure within the Dow Jones index. The company’s performance contributed to a modest overall drop of roughly one‑tenth of a percent for the index, which settled near 52,500 points. Despite the recent dip, the broader market remained positive, having advanced about eight percent since the start of the year. Investors noted that Walt Disney’s share price had moved lower by around one percent, placing it among the more under‑performing names in the index for the day. Market observers highlighted that, while the company’s share value fell, the overall trading volume for the Dow remained robust, underscoring continued liquidity in major equities. The move was part of a broader session where several large‑cap stocks showed modest gains, balancing the overall market momentum.

  • American Express (AXP) traded up 0.58 % and now trades at USD 315.05. American Express has a market capitalisation of USD 211.7 bn. Current price/earnings ratio for American Express is 18.96.

  • Qualcomm (QCOM) traded up 2.1 % and now trades at USD 179.6. Qualcomm has a market capitalisation of USD 189.3 bn. Qualcomm has a current price to earnings ratio of 20.48. Qualcomm Inc. reported a stable earnings outlook for the first half of the year, with guidance that the company expects its revenue to remain broadly in line with prior forecasts and its profit margins to hold steady. The company also reiterated its focus on expanding its portfolio of advanced chip technologies, noting continued investment in research and development for next‑generation processors and system‑on‑chip solutions. While the company’s share price showed modest volatility during the trading session, no significant change was announced in its dividend policy or capital‑structure strategy. No material regulatory filings or strategic initiatives beyond its existing roadmap were disclosed in the latest update.


About Abbott Laboratories

Abbott Laboratories is a health care equipment and supplies company with its main operations in Abbott Park, United States. The company discover, develops, manufactures, and sells a diverse range of health care products and services, including pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products globally through affiliates and distributors, and their website is www.abbott.com . They are listed on the New York Stock Exchange.